本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Acrivon Therapeutics, Inc.

2.03
-0.0600-2.87%
成交量:36.62万
成交额:76.93万
市值:6,385.50万
市盈率:-0.90
高:2.18
开:2.05
低:2.03
收:2.09
52周最高:8.74
52周最低:1.05
股本:3,145.56万
流通股本:1,670.46万
量比:1.09
换手率:2.19%
股息:- -
股息率:- -
每股收益(TTM):-2.2435
每股收益(LYR):-2.3839
净资产收益率:-47.87%
总资产收益率:-30.32%
市净率:0.45
市盈率(LYR):-0.85

数据加载中...

2024/07/10

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/21

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

SEC问询函

Form CORRESP - Correspondence
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/13

SEC问询函

Form CORRESP - Correspondence